MDM2 and acute myeloid leukemia: RG7112 is a Nutlin analog with higher specificity for MDM2 and can induce more robust apoptosis of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL) cells than Nutlin 3a [17].